These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37258980)

  • 1. Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3.
    Yuan L; Cheng F; Wu Z; Li X; Shen W
    Dig Dis Sci; 2023 Aug; 68(8):3324-3340. PubMed ID: 37258980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-
    Bai L; Ge P; Zhang Y; Song Y; Xing R; Zhou D
    Biomed Res Int; 2022; 2022():1080315. PubMed ID: 36158877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.
    Hoshino Y; Hayashida T; Hirata A; Takahashi H; Chiba N; Ohmura M; Wakui M; Jinno H; Hasegawa H; Maheswaran S; Suematsu M; Kitagawa Y
    Mol Cancer; 2014 May; 13():102. PubMed ID: 24885802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
    Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
    Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.
    Xu H; Wu S; Shen X; Wu D; Qin Z; Wang H; Chen X; Sun X
    J Biosci; 2020; 45():. PubMed ID: 32098919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
    Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
    Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis.
    Yao Y; Liu C; Wang B; Guan X; Fang L; Zhan F; Sun H; Li H; Lou C; Yan F; Lu X; Cui L; Liao Y; Han S; Yao Y; Zhang Y
    Cancer Lett; 2022 May; 533():215595. PubMed ID: 35182659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed homeobox B9 regulates oncogenic activities by transforming growth factor-β1 in gliomas.
    Fang L; Xu Y; Zou L
    Biochem Biophys Res Commun; 2014 Mar; 446(1):272-9. PubMed ID: 24582746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.
    Zhussupova A; Hayashida T; Takahashi M; Miyao K; Okazaki H; Jinno H; Kitagawa Y
    PLoS One; 2014; 9(8):e105285. PubMed ID: 25136922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.
    Huang K; Yuan R; Wang K; Hu J; Huang Z; Yan C; Shen W; Shao J
    Chin J Cancer Res; 2014 Feb; 26(1):72-80. PubMed ID: 24653628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB9 promotes endometrial cancer progression by targeting E2F3.
    Wan J; Liu H; Feng Q; Liu J; Ming L
    Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.
    Xiong H; Xiao H; Luo C; Chen L; Liu X; Hu Z; Zou S; Guan J; Yang D; Wang K
    Exp Cell Res; 2019 Oct; 383(1):111493. PubMed ID: 31310747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors.
    Jin Q; Xu L; Wang J; Lin J; Lin H
    Aging (Albany NY); 2023 Jun; 15(11):5096-5124. PubMed ID: 37301547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
    Yang S; Jia R; Bian Z
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells.
    Sui Y; Hu W; Zhang W; Li D; Zhu H; You Q; Zhu R; Yi Q; Tang T; Gao L; Zhu S; Yang T
    Br J Cancer; 2021 Sep; 125(7):1003-1015. PubMed ID: 34247196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold atmospheric plasma enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer by regulating PCAF mediated HOXB9 acetylation.
    Zhang C; Liu H; Li X; Xiao N; Chen H; Feng H; Li Y; Yang Y; Zhang R; Zhao X; Du Y; Bai L; Ma R; Wan J
    Redox Biol; 2024 Sep; 75():103299. PubMed ID: 39127016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
    Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
    Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.
    Zhang J; Chen B; Wang Y; Liu X; Yan H; Wong KY; Chan AK; Cheung AH; Chow C; Xu D; Wang S; Huang B; Liang L; Ke H; Wong CC; Wu WK; Cheng AS; Yu J; Lo KW; To KF; Kang W
    J Pathol; 2023 Aug; 260(4):402-416. PubMed ID: 37272544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
    Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.